Vol 28 (2024): Continuous Publishing
Case report
Published online: 2024-05-06

open access

Page views 329
Article views/downloads 41
Get Citation

Connect on Social Media

Connect on Social Media

Case report

Ascending aortic aneurysm in a young patient with arterial hypertension

Kinga Karolina TyjasKatarzyna Stolarz-SkrzypekAgnieszka OlszaneckaMarek RajzerMarek Stopa
Cracow University Hospital, Kraków, Poland

Address for correspondence: Kinga Karolina Tyjas, Cracow University Hospital, Kraków, Poland; e-mail: tyjas.kinga@gmail.com

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially

Abstract
Aortic aneurysm of the ascending aorta is a condition occurring with a frequency of approximately 2.1% in the population, and its risk increases with age. This case report pertains to a young man with severe primary arterial hypertension and obesity, in whom an ascending aortic aneurysm requiring surgical treatment was diagnosed. Based on the analysis of common risk factors for the development of an ascending aortic aneurysm, his risk of contracting the condition was found to be similar to the population’s risk. The case highlights the need for an individual assessment of the patient regarding potential hypertension-mediated organ damage. Although echocardiography is not recommended by the European Society of Hypertension as a basic screening test for individuals with newly diagnosed arterial hypertension, its performance should be considered for individuals who are obese and/or suffer from arterial hypertension of grade 2 or higher.
Key words: ascending aortic aneurysm; aneurysm; ascending aorta; hypertension; primary arterial hypertension
Arterial Hypertens. 2024, vol. 28, pages: 46–49

Introduction

A 26-year-old smoking male with no cardiac medical history was admitted to the cardiology outpatient department due to arterial hypertension incidentally discovered during routine occupational health examinations about 12 months ago. The patient did not report any complaints apart from intermittent occipital headaches. He worked as a crane operator, smoked about two cigarettes per week, and drank about two beers per week. In the past, he underwent surgery for a left-sided inguinal hernia repair as well as two post-traumatic knee joint surgeries. His father suffered from arterial hypertension too. The patient has been already treated with candesartan 16 mg and hydrochlorothiazide 12.5 mg as a single-pill combination (SPC). He declared that his home blood pressure measurement values fluctuated between 137/90 and 160/110 mm Hg. There were no abnormalities on physical examination except from obesity (body mass index 31.74 kg/m2) and elevated office blood pressure (right arm: 157/103 mm Hg, left arm: 158/107 mm Hg). The electrocardiogram revealed no abnormalities, displaying a regular sinus rhythm at a rate of 65 beats per minute, an intermediate axis, PQ interval of 160 milliseconds, and no ST-T changes. The patient received combination antihypertensive treatment (olmesartan 40 mg, amlodipine 10 mg, hydrochlorothiazide 25 mg in a single pill and nebivolol 5 mg in a separate pill) and reached target blood pressure control within the next 2 months. In accordance with the home blood pressure measurements, the recorded blood pressure values ranged between 120 and 130 mmHg systolic and 70 and 75 mmHg diastolic. In the ambulatory blood pressure monitoring, the mean readings during activity were 120/78 mm Hg, during rest 101/62 mm Hg, with an overall 24-hour average of 114/73 mm Hg. Evaluation of secondary causes of hypertension and organ complications was planned. Blood tests results such as renal, hepatic and thyroid function parameters, cholesterol low-density lipoprotein (LDL), fasting glucose, plasma renin activity, aldosterone and cortisol levels were normal (Tab. 1). He had only an elevated triglyceride level. The 24-hours urine collection test for metoxycatecholamines excretion was also negative. The abdominal ultrasound result was normal. The Doppler ultrasound examination of the renal arteries revealed no stenosis, and the flow parameters were within normal limits: in the right renal artery the peak systolic velocity was 100 cm/s, the renal-to-aortic ratio was less than 1, and the resistance index was 0.62, in the left renal artery the peak systolic velocity was 95 cm/s, the renal-to-aortic ratio was less than 1, and the resistance index was 0.63. Echocardiography revealed enlargement of the ascending aorta to 5.5 cm in diameter, as well as mild to moderate tricuspid aortic valve regurgitation, mild tricuspid and mitral regurgitations, interventricular septum hypertrophy and mild atrial enlargement (Tab. 2, Fig. 1A). An aortic coarctation was excluded. The isolated ascending aortic aneurysm was confirmed on computed tomography scans. The patient was referred to a cardiac surgery clinic and he underwent the Bentall de Bono surgery a few months later (Fig. 1B). He was not presenting the clinical signs of Marfan syndrome or other connective tissue disorders and the genetic investigation was not followed. He had no family history of aortic aneurysm. Despite his young age, the patient met the criteria for the diagnosis of metabolic syndrome (hypertriglyceridemia, obesity and arterial hypertension). He was advised to follow a low-fat and low-calorie diet to achieve weight reduction, but due to the aortic aneurysm, an increase in physical activity before and shortly after the surgery was not recommended. However, after a half-year post-operation, he was able to return to his occupation.

Table 1. Blood test results

Parameter

Test result

Reference

WBC

7.11

4.0010.00 × 103/μL

RBC

5.15

4.505.90 × 106/μL

HGB

15.4

14.018.0 g/dL

HCT

42.4

40.054.0%

PLT

244

140440 × 103/μL

Potassium

4.51

3.505.10 mmol/L

ALT

39

1050 U/I

Creatinine

85.7

62.0106.0 μmol/L

Glucose

4.73

3.305.60 mmol/L

Total cholesterol

3.5

3.25.2 mmol/L

LDL-C

1.4

< 3.4 mmol/L

HDL-C

0.79

> 1.0 mmol/L

Triglycerides

2.90

< 2.26 mmol/L

Uric acid

386

202416 μmol/L

TSH

1.220

0.2704.200 μIU/mL

Aldosterone

189.0

10160 pg/mL at rest,

35300 pg/mL in motion

Plasma renin activity

1.80

0.512.64 ng/mL/h at rest,

0.984.18 ng/mL/h in motion

Cortisol (morning)

10.1

2.319.4 μg/dL

Table 2. Echocardiography result

Parameter

Result

Interventricular wall thickness

13 mm

Posterior wall thickness

10 mm

Diastolic left ventricular internal dimension

57 mm

Systolic left ventricular internal dimension

43 mm

Left ventricular ejection fraction (Biplane)

60%

Left atrium diameter

46 mm

Left atrial volume index (Biplane)

36 mL/m2

Right atrium area

23.6 cm2

Right ventricular outflow tract diameter

37 mm

Right ventricular basal diameter

42 mm

Aortic annulus diameter

30 mm

Aortic root diameter

47 mm

Sinotubular junction diameter

52 mm

Ascending aorta diameter

55 mm

Aortic arch diameter

20 mm

Descending (abdominal) aorta diameter

20 mm

Left ventricular outflow tract diameter

24 mm

Inferior vena cava diameter

14 mm

Aortic regurgitation grade

Mild/moderate

(vena contracta 5 mm, pressure half time 615 ms)

Mitral regurgitation grade

Mild

Tricuspid regurgitation grade

Mild

Tricuspid regurgitation velocity

2.57 m/s

Pulmonic regurgitation grade

Mild

Mitral inflow pattern

Normal

(E = 75 cm/s, A = 60cm/s, E/A = 1.26)

Aortic valve velocity

1.41 m/s

Pulmonic valve velocity

0,67 m/s

51574.png
Figure 1. A. Dilation of ascending aorta in echocardiography. 1 aortic root diameter (4.7 cm), 2 sinotubular junction diameter (5.2 cm), 3 (5.5cm). B. Post Bentall de Bono operation status. Artificial aortic valve St Jude Medical (SJM) ascending aorta diameter Masters 25 VAVGJ and ascending aorta vascular prosthesis in echocardiography. 1 aortic root prosthesis diameter (3.5 cm), 2 sinotubular junction prosthesis diameter (2.9 cm), 3 ascending aorta prosthesis diameter (2.9 cm)

The prevalence of aortic dilatation defined as diameter of minimum 4 cm is estimated at 2.1% and has a strong correlation with male sex and older age [1]. The incidence of dilatation of ascending aorta is increasing, so the present prevalence may be even higher [2]. That observation is probably associated with the rising number of computed tomography scans performed every year for any reason. Symptoms of ascending aorta aneurysm usually do not occur, but chronic chest pain may be present rarely. That is why this condition is found mostly accidentally [3]. The risk factors of ascending thoracic aortic aneurysm are older age, body surface area above 1,7 m2, arrhythmia, aortic valve disease, arterial hypertension and family history of aortic aneurysm [4]. Common screening criteria are not available; however, the risk algorithm for ascending aortic aneurysm has been published recently [4]. According to that algorithm the presented patient would have about 2% risk of disease. Besides male gender, he had only two risk factors for the development of an aortic aneurysm obesity (high body surface area 2.46 m2) and arterial hypertension. It is not surprising that the prevalence of ascending aortic dilatation is quite rare in patients under the age of 50 [1]. However, the case demonstrates that echocardiography, which is not recommended as a basic screening test for hypertension-mediated organ damage for all hypertensive patients, should be considered in cases when the patient has an elevated body surface area or has a high severity of hypertensive disease [5]. It is impossible to determine whether arterial hypertension caused the development of an aortic aneurysm in this patient or if the aneurysm occurred independently because of unknown reasons. Nevertheless, uncontrolled arterial hypertension, especially high diastolic blood pressure, certainly contributes to the dilation of the aortic root. The surgery has obviously reduced the patient’s susceptibility to aortic diseases, but his cardiovascular risk remains elevated due to persistent chronic diseases requiring further monitoring.

Ethics statement

This case report does not involve any experimental research on animals or human patients, ethical approval is not necessary.

Author contributions

K.S.-S. contributed to the study conception. Data collection was performed by K.S.-S., A.O. and M.S.. Material preparation and writing of manuscript was covered by K.T. K.S.-S., M.R. and A.O. edited and reviewed the manuscript. All authors read and approved the final version of the manuscript.

Acknowledgments

None.

Conflict of interest

Authors declare no conflict of interests.

References

  1. Mori M, Bin Mahmood SU, Yousef S, et al. Prevalence of Incidentally Identified Thoracic Aortic Dilations: Insights for Screening Criteria. Can J Cardiol. 2019; 35(7): 892–898, doi: 10.1016/j.cjca.2019.03.023, indexed in Pubmed: 31292088.
  2. Lodewyks CL, Prior HJ, Hiebert BM, et al. A Province-Wide Analysis of the Epidemiology of Thoracic Aortic Disease: Incidence Is Increasing in a Sex-Specific Way. Can J Cardiol. 2020; 36(11): 1729–1738, doi: 10.1016/j.cjca.2019.11.013, indexed in Pubmed: 32527665.
  3. Erbel R, Aboyans V, Boileau C, et al. Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw rozpoznawania i leczenia chorób aorty. [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. Kardiol Pol. 2014; 72(12): 1169–1252, doi: 10.5603/KP.2014.0225, indexed in Pubmed: 25524604.
  4. Mori M, Gan G, Deng Y, et al. Development and Validation of a Predictive Model to Identify Patients With an Ascending Thoracic Aortic Aneurysm. J Am Heart Assoc. 2021; 10(22): e022102, doi: 10.1161/JAHA.121.022102, indexed in Pubmed: 34743563.
  5. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023; 41(12): 1874–2071, doi: 10.1097/HJH.0000000000003480, indexed in Pubmed: 37345492.